Final Adult Height in Girls Treated with GnRH Analogues for Precocious Puberty Around Age Eight
<b>Introductions:</b> Precocious puberty initiated at a very young age causes a severe loss in height potential and should be treated with gonadotropin-releasing hormone agonists (GnRHa). Controversial findings exist regarding the efficacy of GnRHa treatment in girls with central precoci...
Saved in:
| Main Authors: | Semra Bahar Akın, İlker Tolga Özgen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9067/12/6/756 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical appraisal of diagnostic laboratory tests in the evaluation of central precocious puberty
by: Kanthi Bangalore Krishna, et al.
Published: (2025-01-01) -
Influence of GnRH analog therapy on body mass in central precocious puberty
by: Anna Noczyńska, et al.
Published: (2009-03-01) -
Combination therapy of GnRHa, RhGH and anastrozole to improve final adult height deficit in CAH children with CPP
by: Xiaoxiao Liu, et al.
Published: (2025-05-01) -
Retrospective Analysis on the Impact of Triptorelin on Final Height of Girls with Precocious and Early Puberty: A Single-Center, Long-Term Study
by: Georgia Sotiriou, et al.
Published: (2025-06-01) -
The Effect of GnRH Analogs on Body Mass Index in Girls with Central Precocious Puberty: A Single-Center Retrospective Study with a Literature Review
by: Ignazio Cammisa, et al.
Published: (2025-03-01)